Diabetes in Control speaks with top endocrinologists and other medical professionals to bring you the latest in diabetes news and research. This week, we have another exclusive interview from ADA 2017.
Joel Goldsmith is the Senior Director of Digital Platforms at Abbott Diabetes Care, which is focused on designing, developing, and commercializing software-based products and services that drive trial and sustained utilization of ADC’s sensor-based glucose monitoring solutions. A founding member of the product innovation team at Abbott Diabetes Care, Joel was the driving force behind the conception, design, development, and commercialization of the system. He and his team created the FreeStyle Libre system, which comprises a tiny glucose sensor (0.2 inches in length, about the thickness of a hair) inserted through the skin and connected to a small, water resistant, plastic patch on the skin’s surface. The sensor remains in place for 14 days. To obtain readings, users hold a touchscreen reader device close to the sensor patch and wait for it to beep. In less than a second, users can see their real-time glucose value, a trend arrow, and a graph showing the last eight hours of their glucose history. Information displayed on the reader can be downloaded to a computer. A US version designed for use by health care professionals and available by prescription only, the Freestyle Libre Pro, was approved by the FDA in September of 2016. A US consumer version of the technology is currently under FDA review.
Featured videos include:
or view the complete interview here: Complete Interview.